A nurse is caring for a client who is experiencing preterm labor at 29 weeks of gestation and has a prescription for betamethasone. Which of the following statements should the nurse make about the indication for medication administration?

Choice A Reason:

Confirming the newborn's Apgar score is important for assessing the newborn's overall condition, but it may not be the first priority.

Choice B Reason:

Verifying the newborn's identification is appropriate. Ensuring accurate identification is a crucial step in newborn care to prevent errors and ensure that interventions are carried out on the correct infant.

Choice C Reason:

Administering vitamin K is a standard practice but can wait until after the newborn's identification is confirmed.

Choice D Reason:

Determining obstetrical risk factors is part of the overall assessment but is not the immediate priority in this situation.

A. "This medication will stop your labor": Betamethasone is not intended to stop labor. It is given to promote fetal lung maturity and reduce the risk of complications associated with preterm birth.

B. "This medication stimulates fetal lung maturity": This is the correct statement. Betamethasone is administered to enhance the production of surfactant in the fetal lungs, improving respiratory outcomes for the preterm infant.

C. "This medication will decrease your risk for uterine infections": Betamethasone does not directly decrease the risk of uterine infections. Its primary benefit is in promoting fetal lung maturity.

D. "This medication will increase your baby's weight": Betamethasone is not given to increase the baby's weight. Its main focus is on improving lung function and reducing respiratory complications in preterm infants.